Cipla, Macleods HIV child treatments approved in South Africa

The treatment combines four antiretroviral treatments.
Image: Shutterstock
South Africa, which has the world’s biggest number of people infected with HIV, has approved Cipla Ltd.’s quadrimune, a treatment for children infected with the virus, for use.

Quadrimune comes in the form of sweet-tasting granules that can be sprinkled on soft food or dissolved in mill or water, the South African Health Products Regulatory Authority said in a statement on Friday. The treatment combines four antiretroviral treatments.

Dolutegravir tablets, made by Macleods Pharmaceuticals Ltd., for the treatment of children with HIV, were also registered for use.

About 13% of South Africa’s population, or 8.2 million people, are infected with HIV, according to the national statistics agency.

© 2022 Bloomberg L.P.

COMMENTS   0

You must be signed in and an Insider Gold subscriber to comment.

SUBSCRIBE NOW SIGN IN

LATEST CURRENCIES  

USD / ZAR
GBP / ZAR
EUR / ZAR
BTC / USD

Subscribe to our mailing list

* indicates required
Moneyweb newsletters

Instrument Details  

You do not have any portfolios, please create one here.
You do not have an alert portfolio, please create one here.
INSIDER SUBSCRIPTION APP VIDEOS RADIO / LISTEN LIVE SHOP OFFERS WEBINARS NEWSLETTERS TRENDING

Follow us:

Search Articles:
Click a Company: